Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.9 |
mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |